2000
Regional Lymph Node Dissections In Malignant Melanoma
Lawton G, Ariyan S. Regional Lymph Node Dissections In Malignant Melanoma. Clinics In Plastic Surgery 2000, 27: 431-440. PMID: 10941563, DOI: 10.1016/s0094-1298(20)32738-3.Peer-Reviewed Original ResearchConceptsElective lymph node dissectionLymph node dissectionNode dissectionNegative nodesTherapeutic lymph node dissectionRegional lymph node dissectionSentinel lymph node dissectionClinical stage ITime of resectionPositive nodesRegional lymphadenectomySentinel lymphProphylactic excisionCutaneous melanomaPrimary tumorMalignant melanomaPrimary melanomaRegional nodesSurvival advantageStage IPatientsMetastatic cellsMelanomaDissectionClear benefitLymphatic Mapping And Sentinel Lymph Node Biopsies
Ali-Salaam P, Ariyan S. Lymphatic Mapping And Sentinel Lymph Node Biopsies. Clinics In Plastic Surgery 2000, 27: 421-429. PMID: 10941562, DOI: 10.1016/s0094-1298(20)32737-1.Peer-Reviewed Original Research
1982
Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities.
Ariyan S, Kirkwood J, Mitchell M, Nordlund J, Lerner A, Papac R. Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities. Surgery 1982, 92: 459-63. PMID: 7112396.Peer-Reviewed Original ResearchConceptsBacillus Calmette-GuerinSurgical adjuvant immunotherapyMER-BCGAdjuvant immunotherapyControl groupHigh-risk malignant melanomaDisease-free survivalHigh-risk melanomaIntraoperative infiltrationImmunotherapy groupIntradermal vaccinationIntralymphatic immunotherapyRegional lymphadenectomyConsecutive patientsSurgical excisionCalmette-GuerinMalignant melanomaPatientsImmunotherapyMethanol-extractable residueLymphadenectomyRecurrenceMelanomaExtremitiesSame interval